A rhodamine chromene-based turn-on fluorescence probe for selectively imaging Cu²+ in living cell

Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy
Wei-Yong LiuJun-Ying Miao

Abstract

We describe the development of a rhodamine chromene-based turn-on fluorescence probe to monitor the intracellular Cu(2+) level in living cells. The new fluorescent probe with a chlorine group in chromene moiety exhibits good membrane-permeable property than previous reported because the predicted lipophilicity of present probe 4 is stronger than that of methoxyl substituted probe in our previous work (CLogP of 4: 8.313, CLogP of methoxyl substituted probe: 7.706), and a fluorescence response toward Cu(2+) under physiological conditions with high sensitivity and selectivity, and facilitates naked-eye detection of Cu(2+). The fluorescence intensity was remarkably increased upon the addition of Cu(2+) within 1 or 2 min, while the other sixteen metal ions caused no significant effect.

References

Apr 20, 2004·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Rolf A Løvstad
May 28, 2004·Endocrine-related Cancer·V L GoodmanS D Merajver
Mar 20, 2010·Analytical and Bioanalytical Chemistry·Cyril Petibois
Nov 26, 2010·Chemical Society Reviews·Ha Na KimHe Tian
Dec 16, 2010·The Analyst·Yang-Wei LinHuan-Tsung Chang
Nov 22, 2011·Chemical Communications : Chem Comm·Sakan SirilaksanapongPaitoon Rashatasakhon

❮ Previous
Next ❯

Citations

Dec 18, 2013·Journal of Fluorescence·Sheng-Qing WangBao-Xiang Zhao
Mar 22, 2013·Journal of Fluorescence·Meng-Meng LiBao-Xiang Zhao
Jun 12, 2013·Journal of Molecular Modeling·Tasawan KeawwangchaiSomchai Keawwangchai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.